Remicade 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FA1KV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,680
Award facts
- Contract value 100% obligated
- $12,680.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,680.36 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract, awarded on January 26, 2026, carries a firm fixed-price structure with an ultimate completion date of January 27, 2026. This delivery order represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables comprehensive medical supply delivery to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio under the DLA IDC encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This particular delivery order for Remicade, a specialized immunosuppressant medication, demonstrates the contractor's capability to fulfill federal requirements for critical pharmaceutical commodities through established contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FA1KV?
SPE2DR26FA1KV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FA1KV worth?
The government has obligated $12,680 on SPE2DR26FA1KV.
Is contract SPE2DR26FA1KV an order under another contract?
Yes. SPE2DR26FA1KV is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1KV competed?
The extent of competition for SPE2DR26FA1KV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award